中文

R&D 

Copyright(c)2019 Qilu Pharmaceutical Co., Ltd. 鲁ICP备06006222号 Headquarter Address: 8888 Lvyou Road, High-tech Zone, Jinan, 250104, China

PRODUCTS

MANUFACTURING

NEWS

CONTACT US

ABOUT US

Qilu Pharma Announces Launch of a Generic Version of Vesicare® in the United States

Classification:
Company news
Author:
QILU PHARMACEUTICAL
Source:
QILU PHARMACEUTICAL
Release time:
2019/05/20 09:51
Page view
[Abstract]:

May 20, 2019—Qilu Pharmaceutical today announced the U.S. approval and launch of Solifenacin Succinate Tablets, which makes the third Day 181 launched product for Qilu in US.

Up to now, Qilu has launched thirteen products in US and among them, ten products are the injectables. 

 

NEWS